SeaStar Medical Holding Price, Forecast, Insider, Ratings, Fundamentals & Signals

Denver, april 30, 2024 (globe newswire) -- seastar medical holding corporation (nasdaq: icu), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that the national institutes of health's (nih) national heart, lung, and blood institute has awarded a $3.6 million grant for a clinical trial to evaluate the selective cytopheretic device adult (scd-adult, a member of the company's quelimmune™ product family) as a bridging strategy to left ventricular assist device (lvad) implantation in patients with chronic heart failure (chf) who have progressed to acute decompensated heart failure (adhf). this grant award follows a breakthrough device designation for cardiorenal syndrome granted by the u...

New york , april 28, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of seastar medical holding corporation ("seastar" or the "company") (nasdaq: icu). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.

New york , april 20, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of seastar medical holding corporation ("seastar" or the "company") (nasdaq: icu). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.

Denver, april 17, 2024 (globe newswire) -- seastar medical holding corporation (nasdaq: icu) (“seastar medical” or the “company”), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports financial results for the 12 months ended december 31, 2023 and provides a business update.

New york , april 12, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of seastar medical holding corporation ("seastar" or the "company") (nasdaq: icu). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.

DENVER, April 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18 at 9:30 a.m. Eastern time. The formal presentation will be followed by a hosted question-and-answer session.

March 13 webcast showcasing Quelimmune ™ scientific background and clinical data for pediatric AKI due to sepsis or a septic condition will be available on seastarmedical.com

Despite a recent decline in the leading economic index, the U.S. economy is positioned for a positive future in 2024. Strong employment and robust stock levels contribute to the optimistic outlook.

SeaStar Medical Holding (NASDAQ: ICU) stock price has done well this year even as the company continued diluting its shareholders. The stock is about to hit $1, meaning that it has surged by more than 177% from the lowest point in December and by 495% from its 2023 low.

Trading penny stocks can be a risky endeavor, but having access to quality news and information can help mitigate some of that risk. As an investor or trader, it's critical to understand how news events can impact penny stocks and how to use news to your advantage when developing your trading strategy.

Shares of SeaStar Medical Holding Corp. ICU, +70.05% rocketed 45.3% on heavy volume in premarket trading Thursday, to take them back above the $1 mark for the first time in five months. Trading volume spiked to 21.4 million shares ahead of the open, to already match the full-day average.

DENVER, Oct. 05, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present a company overview at the 8th Annual Dawson James Small Cap Growth Conference on Thursday, October 12 at 2:30 p.m. Eastern time (11:30 a.m. Pacific time). The conference is being held at the Wyndham Grand Harborside Hotel in Jupiter, Fla.

Underlying prices exhibited a notable cooling trend, providing the Federal Reserve shows evidence of softer inflation. While Americans did indeed spend more on costly gasoline and services during the month, this moderation in other price components underscores the nature of inflationary pressures.

DENVER, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will hold a business update conference call today at 4:00 p.m. Eastern time (1:00 p.m. Pacific time). During the call, management will provide a clinical and regulatory update and review the Company's value proposition, including the commercial opportunity.

SeaStar Medical (NASDAQ: ICU ) stock is on the rise Thursday as the medical technology company's shares see plenty of activity today. During the early trading hours, some 6 million shares of ICU stock changed hands.